Serum and urine cystatin C are poor biomarkers for acute kidney injury and renal replacement therapy. - Wikidata - wikimedia - TriplyDB

Serum and urine cystatin C are poor biomarkers for acute kidney injury and renal replacement therapy.

Serum and urine cystatin C are poor biomarkers for acute kidney injury and renal replacement therapy.

http://www.wikidata.org/entity/Q34588093

about

Biomarkers, diagnosis and management of sepsis-induced acute kidney injury: a narrative review Cystatin C: a new renal marker and its potential use in small animal medicine A basic science view of acute kidney injury biomarkers.The impacts of thyroid function on the diagnostic accuracy of cystatin C to detect acute kidney injury in ICU patients: a prospective, observational study.Comparison of serum creatinine and serum cystatin C as biomarkers to detect sepsis-induced acute kidney injury and to predict mortality in CD-1 mice Evidence of uncoupling between renal dysfunction and injury in cardiorenal syndrome: insights from the BIONICS study.Utility of serum creatinine/cystatin C ratio in diagnosis of postrenal acute kidney injury Diagnostic value of neutrophil gelatinase-associated lipocalin, cystatin C, and soluble triggering receptor expressed on myeloid cells-1 in critically ill patients with sepsis-associated acute kidney injury Year in review in Intensive Care Medicine 2011: I. Nephrology, epidemiology, nutrition and therapeutics, neurology, ethical and legal issues, experimentals.Marking renal injury: can we move beyond serum creatinine?Role of biomarkers of nephrotoxic acute kidney injury in deliberate poisoning and envenomation in less developed countries Urine interleukin-18 and cystatin-C as biomarkers of acute kidney injury in critically ill neonates.Serum cystatin is a useful marker for the diagnosis of acute kidney injury in critically ill children: prospective cohort study Correlations of serum cystatin C and glomerular filtration rate with vascular lesions and severity in acute coronary syndrome Nephrotoxicity-induced proteinuria increases biomarker diagnostic thresholds in acute kidney injury Role of new biomarkers: functional and structural damage Clinical review: Biomarkers of acute kidney injury: where are we now?A comparison of RIFLE with and without urine output criteria for acute kidney injury in critically ill patients.Serum cystatin C is a poor biomarker for diagnosing acute kidney injury in critically-ill children Distinct injury markers for the early detection and prognosis of incident acute kidney injury in critically ill adults with preserved kidney function.Serum cystatin C as a marker of renal function in critically ill patients with normal serum creatinine Are recently reported biomarkers helpful for early and accurate diagnosis of acute kidney injury?Biomarkers for the prediction of acute kidney injury: a narrative review on current status and future challenges.Novel biomarkers of acute kidney injury in the general adult ICU: a review.Biomarkers in the assessment of acute and chronic kidney diseases in the dog and cat.Predicting acute kidney injury: current status and future challenges.Serum creatinine and cystatin C provide conflicting evidence of acute kidney injury following acute ingestion of potassium permanganate and oxalic acid.Value of Serum Cystatin C Measurement in the Diagnosis of Sepsis-Induced Kidney Injury and Prediction of Renal Function Recovery.Comparison of different equations to assess glomerular filtration in critically ill patients.Systemic and urinary neutrophil gelatinase-associated lipocalins are poor predictors of acute kidney injury in unselected critically ill patients.Novel biomarkers for the prediction of acute kidney injury in patients undergoing liver transplantation.Cystatin C is not a reliable marker of residual glomerular filtration rate during continuous renal replacement therapy.Critical research on biomarkers: what's new?Effects of Oral Prednisone Administration on Serum Cystatin C in Dogs.Impact of sepsis on levels of plasma cystatin C in AKI and non-AKI patients.Analytical validation of a human particle-enhanced nephelometric assay for cystatin C measurement in feline serum and urine.Serum cystatin C and microalbuminuria in burn patients with acute kidney injury.Urinary cystatin C levels as a diagnostic and prognostic biomarker in patients with acute kidney injury.Biomarkers for prediction of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis.Early biomarkers of renal injury and protective effect of erythropoietin on kidneys of asphyxiated newborn rats

P2860

Q26825317-94BBC1C2-9C11-4BB0-A611-142AFE30D822 Q27010861-042107D2-C09C-4674-9D53-7E5EF9F6E8B3 Q30384522-359C7F31-9E87-4C05-BF8C-983EB4BB3360 Q33751865-16C26839-58DD-45F6-9593-87ABC6E85BF0 Q34355926-5BDA85E4-DB15-4AD0-93F9-32CB01931006 Q34489305-D761640D-621B-49A6-9AB7-14EDF8C32556 Q35025281-87475242-684C-4620-BF62-92CABB77065B Q35666873-869771F6-E1B8-4039-9912-56A174CACC70 Q35795306-E73A16BD-A37F-4824-AA0B-54C3AF456DF6 Q35841388-68D242A0-D088-4205-B542-24B567DBFD60 Q35846103-328EFAF2-F017-4DDF-8933-F26A5B0CF494 Q35861370-B8CF70A4-E1F3-470C-90D1-A98219697742 Q36131829-69CE92F5-375E-4752-8614-670A7E615904 Q36265357-860B3ABF-45C7-4614-8115-E6A0BE1FA6DA Q36333111-7BF95E5D-FB7E-40CD-8819-220D54765B58 Q36622423-732C5CAB-F0AD-48A0-AE2E-FD7DE96BE9FC Q36928048-BEAF282D-74CD-4BDC-8DC5-727647B6E581 Q36928243-71D8946A-999A-4628-883B-FC6AAD425E0D Q37119704-DA3C467D-B3CF-4687-9A83-1860EF20E9E9 Q37211307-0A789F26-DAA1-46AB-AA68-A0A30E2E1FC9 Q37720428-9BF48246-4435-4059-BD84-860F82A65EAA Q38003686-96E1C8B6-DB06-4D5C-8013-62D4436EFF38 Q38029606-D0B75332-583D-493D-B00C-F1E4B6204C42 Q38087654-C0672767-D1FF-4E5D-A6B5-0FACA0D2A9DD Q38154953-6B94B2A0-7789-4CCE-A79A-553E51F7AD31 Q38669818-31DBC83B-19C1-47F2-8BD6-99DC0BD99F1A Q38769018-3554F422-37F9-4DDC-8000-6094D1992646 Q40282377-E167AA1F-060C-4FCA-9CA9-82D6B91C9B4A Q41529887-4EAB3657-CC42-4CCC-937D-FB567E09589A Q41643232-7DF48CF9-FA31-4DD2-AAE8-770C43FFDDE7 Q42253777-D7B4D8FA-9804-4E5F-B1EC-1C504F1B3BF1 Q42942433-7F8A64C3-F4C5-4E2F-B1A4-D5B6C824658D Q45055427-12C581AA-D50A-47B5-BF3C-87EE5F03DF8F Q47149470-AFE93477-6EDD-49C2-9C0A-36E9656B4393 Q48247147-38A82CA8-E131-4CD8-B52E-BE2CD91107B7 Q49073040-7FFFDAFB-D2DD-4966-902D-2931E258CA1B Q50928238-25004CA7-FA44-4F36-9858-EC4A92BB5DF4 Q53340836-9FD28CE1-458D-475D-A92B-B69146CAA7D8 Q55385257-DC66C08A-FB6E-4627-B090-C9B15346FCC9 Q57938924-2C734D36-0AF5-4E71-A0E8-76D41AA0CBFD

P2860

Serum and urine cystatin C are poor biomarkers for acute kidney injury and renal replacement therapy.

http://www.wikidata.org/entity/Q34588093

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Serum and urine cystatin C are ...... and renal replacement therapy.

@ast

Serum and urine cystatin C are ...... and renal replacement therapy.

@en

Serum and urine cystatin C are ...... and renal replacement therapy.

@nl

type

label

Serum and urine cystatin C are ...... and renal replacement therapy.

@ast

Serum and urine cystatin C are ...... and renal replacement therapy.

@en

Serum and urine cystatin C are ...... and renal replacement therapy.

@nl

prefLabel

Serum and urine cystatin C are ...... and renal replacement therapy.

@ast

Serum and urine cystatin C are ...... and renal replacement therapy.

@en

Serum and urine cystatin C are ...... and renal replacement therapy.

@nl

P1433

Q34588093-DA9E9D8A-C0E7-4801-8705-489208A2C5E3

P1476

Q34588093-D64345F5-764D-4FD5-9CDB-FF5CF93D857D

P2093

Q34588093-09E66556-D908-40FC-91C7-076995888DB0

Q34588093-69BD4D30-04DF-4DB8-85FD-7D0E11424271

Q34588093-B015CE89-8576-4B1C-B778-B8508CAE87DA

Q34588093-CF6E88FD-2C91-4243-982E-A433E4CE5163

Q34588093-D75F0B92-BA92-4602-BDE1-DDE4407CBCB0

Q34588093-DB28AA8D-1506-443F-8978-0201EDB05FDB

P2860

Q34588093-019FA5C9-CFEA-4DF2-BD84-0CE826320C88

Q34588093-0301991D-9BB3-4624-9842-336E3558E2CB

Q34588093-08AB86D3-884F-439A-BDA7-E9E875441F8C

Q34588093-0C46CEE9-BAEC-4286-9FC6-85A394EAB626

Q34588093-10E83FF3-7A2E-41D5-89EB-6EA94001FFC3

Q34588093-131E20F7-BED2-42EA-AFDD-0877E8DD240C

Q34588093-2468C030-8EC8-425C-B4A4-56BA0ADD13DB

Q34588093-25C49113-4B18-4373-A301-74E97F0F577B

Q34588093-301FC8A3-31DC-4795-B49B-21B1F781C4DB

Q34588093-34BC53E4-62AA-4576-85A9-2EB355D4C9EB

P2888

Q34588093-897ECF0C-DFF4-4F96-9792-ECE797086A98

P304

Q34588093-8F678608-BF7B-420A-8FD6-F0853375DCE4

P31

Q34588093-BFC467EF-57C4-4C39-9680-ECB8DEFA9E97

P356

Q34588093-91BA9BC0-A7C0-424B-8913-C18FF9C0AAAA

P433

Q34588093-147B502E-BD40-400A-A4CF-F56F342AAB1B

P478

Q34588093-52C697AE-B4E5-4B3E-987D-F3FC22FDBCE8

P50

Q34588093-5F85C697-F17C-418F-B091-80778161AFC5

Q34588093-D79EE54E-1D5F-4E37-9373-8BE612031698

P577

Q34588093-ABCBA274-1B9C-470C-9CCE-82D655D94B10

P5875

Q34588093-B748749A-354A-4890-8F3F-EEBD5BDCCD8B

P698

Q34588093-DE71A694-288C-453B-8F4D-913A7477B109

P921

Q34588093-67024354-1BCD-4329-B5A4-64C49ED4E099

P932

Q34588093-0E8E72A7-EB79-472A-AE93-7B6BD4DD3DFB

P356

S00134-010-2087-Y

P1433

Intensive Care Medicine

P1476

Serum and urine cystatin C are ...... and renal replacement therapy.

@en

P2093

Annick A N M Royakkers

http://www.w3.org/2001/XMLSchema#string

Catherine S C Bouman

http://www.w3.org/2001/XMLSchema#string

Jeroen D E van Suijlen

http://www.w3.org/2001/XMLSchema#string

Johanna C Korevaar

http://www.w3.org/2001/XMLSchema#string

Lieuwe S Hofstra

http://www.w3.org/2001/XMLSchema#string

Peter E Spronk

http://www.w3.org/2001/XMLSchema#string

P2860

Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury

Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group

Serum cystatin C concentration as a marker of acute renal dysfunction in critically ill patients

Cystatin C: unsuited to use as a marker of kidney function in the intensive care unit

Impact of thyroid dysfunction on serum cystatin C

Effect of corticosteroid therapy on serum cystatin C and beta2-microglobulin concentrations

APACHE II: a severity of disease classification system

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study

Pharmacologic treatment of acute kidney injury: why drugs haven't worked and what is on the horizon.

P2888

s00134-010-2087-y

P304

493-501

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00134-010-2087-Y

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P50

Marcus J Schultz

P577

2010-12-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49679031

http://www.w3.org/2001/XMLSchema#string

P698

21153403

http://www.w3.org/2001/XMLSchema#string

P921

P932

3042095

http://www.w3.org/2001/XMLSchema#string